Dydrogesterone
General information:
| Withdrawn ID: | DB00378 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | G03DB01 |
| Molecular Formula: | C21H28O2 |
| Molweight: | 312.446 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1961 |
| First withdrawn: | 2008 |
| Last withdrawn: | 2008 |
Side-effects:
| Total reported cases (submitted by medical professionals) with Dydrogesterone as primary suspect: | 5 |
|---|
Reported final outcomes:
| Congenital anomaly: | 2 |
|---|---|
| Hospitalization (initial or prolonged): | 1 |
Reported side-effects:
| Side-effect | Case number |
|---|---|
| Foetal exposure during pregnancy | 3 |
| Pseudohermaphroditism female | 2 |
| Labia enlarged | 2 |
| Enlarged clitoris | 2 |
| Blood testosterone increased | 2 |
| UTERINE RUPTURE | 1 |
| PREMATURE LABOUR | 1 |
| Hypospadias | 1 |
| Abortion induced | 1 |
Toxicity information:
| Toxicity class: | 5 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 4600 mg/kg |
External links:
| ChEBML: | CHEMBL1200853 |
|---|---|
| DrugBank: | DB00378 |